Drupal.behaviors.print = function(context) {window.print();window.close();}>
InteRNA Technologies, Silence Therapeutics to Co-Develop miRNA Cancer Drugs
September 15, 2011
InteRNA Technologies, Silence Therapeutics to Co-Develop miRNA Cancer Drugs
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Silence Inks Delivery Tech Evaluation Deal with Mireven
August 23, 2012 / Gene Silencing News
Regulus Inks microRNA Drugs Collaboration with AstraZeneca
August 16, 2012 / Gene Silencing News
Silence Inks Tech-Evaluation Deal with Miragen
January 12, 2012 / Gene Silencing News
Mirna to Evaluate Silence Delivery Technologies for microRNA Drug Candidates
October 27, 2011 / Gene Silencing News
MDRNA Inks Early-Stage Collaboration Related to miRNA Therapies
May 6, 2010 / Gene Silencing News